Automating Circulating Tumor Cell Isolation and Transfer
Webinar

Automating Circulating Tumor Cell Isolation and Transfer

Andris Abramenkovs will discuss how the latest automated cell isolation technology streamlines circulating tumor cell applications. 

Share

This webinar will be hosted live and available on-demand

Tuesday, December 5, 2023 
10:00 AM Eastern Time 

Circulating tumor cells (CTCs) are considered precursors to metastasis. They mirror tumor heterogeneity and can be found in the bloodstream as either single CTCs or clusters. Non-invasive liquid biopsies from patient blood samples can provide insight into the biological and molecular characteristics of the primary tumor, as well as the different tumor phenotypes present, enabling optimization of treatment strategies and improved patient outcomes. However, numerous issues complicate accurate CTC characterization, including low circulating numbers in the blood, diminished viability, cell loss during enrichment, and white blood cell contamination. 

In this webinar brought to you by Sartorius, Andris Abramenkovs will highlight the utility of the CellCelector platform for isolating a wide range of CTC subtypes, drawing from the extensive literature evidence base.

Topics to be covered 

  • How the CellCelector automated cell isolation and transfer platform addresses the traditional challenges of rare cell isolation and enrichment
  • Rapid identification, characterization, and transfer of single CTCs or clusters
  • Identification and transfer of rare cells using custom developed consumables, powerful imaging and image analysis, and gentle single cell or cluster transfer
Andris

Andris Abramenkovs, PhD
Product Manager
Sartorius


Top Image Credit:

Automating Circulating Tumor Cell Isolation and Transfer

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies